Tweet
<img alt="" height="1" width="1" />
Pfizer studies back pneumococcal shot for adults
BusinessWeek
Two key late-stage studies of Pfizer's blockbuster pneumococcal vaccine for children show it works at least as well as a rival in adults, a big market the drugmaker wants to tap. The studies of Pfizer Inc.'s Prevnar 13 vaccine ...
Is Prevnar 13 Pfizer's next big thing?TheDay.com
Pfizer Pneumonia Shot Shown Effective in Ages 50 and OlderBloomberg
Prevnar 13 Vaccine For Pneumococcal Disease For Adults Meets All EndpointsMedical News Today
Zenopa -The Pharma Letter -The FINANCIAL
all 152 news articles »
More...